Browsing Tag
Molnupiravir
6 posts
CDC tracks BA.3.2 Cicada COVID variant across 25 US states as WHO flags immune escape risk
CDC tracks BA.3.2 Cicada COVID variant across 25 US states and 23 countries. The heavily mutated SARS-CoV-2 strain raises immune escape and vaccine efficacy concerns.
March 28, 2026
Aurobindo Pharma gets DCGI nod for Molnupiravir generic version
Aurobindo Pharma has secured consent from the Drugs Controller General of India (DCGI) for manufacturing and distributing its…
December 29, 2021
Cipla, Dr. Reddy’s, and others to collaborate on Molnupiravir Covid trial
Five Indian pharma companies – Cipla, Dr. Reddy’s Laboratories, Emcure Pharmaceuticals, Sun Pharmaceutical Industries, and Torrent Pharmaceuticals will…
June 29, 2021
Suven Pharma partners with CSIR-IICT to manufacture Molnupiravir and 2-DG
Suven Pharmaceuticals (Suven Pharma), CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad and CSIR-National Institute of Interdisciplinary Science &…
June 10, 2021
Divi’s Laboratories to manufacture API of MSD’s Covid drug Molnupiravir
Divi’s Laboratories Limited has been selected by pharma giant MSD (known as Merck in the US and Canada)…
May 27, 2021
Cipla partners with MSD to manufacture and distribute Molnupiravir drug to treat Covid-19
Cipla has entered into a non-exclusive licensing agreement with MSD (called Merck in the US and Canada) for…
April 28, 2021